Practice points
This study suggests that professionals (nurses, doctors, pharmacists and teachers) would support female-controlled prevention options particularly the vaginal microbicides.
Factors associated with willingness to use the femalecontrolled options were HIV risk perception, marital status, profession, and duration in profession.
Such support would inform the design of appropriate interventions to prepare these professionals for the eventual advent of an effective microbicide as a HIV/AIDS prevention option. 1, 7 prevalence of HIV in Bangladesh is still very low, the by HIV. In many parts of the world, more than half of all country remains vulnerable to HIV because of proximity to the new HIV infections occur among women, and most of [1] [2] [3] [4] [5] [6] [7] high HIV prevalence countries with similar behavioral risk these infections occur through sexual routes. To control characteristics. For example, like in many other Asian this situation, and considering the various social, cultural countries, partner violence and unprotected commercial sex and religious barriers already described above, an 7 are common in Bangladesh. In the fourth round of national HIV/AIDS prevention option which is largely controlled by serological surveillance the HIV prevalence among injection women is desirable. With limited prospects of HIV vaccine drug users was 4%, but remains less than 1% among other and continued escalation of HIV, microbicides and female vulnerable groups such as commercial sex workers and men condoms have been proposed as potentially viable option 7 8,9 who have sex with men. The government of Bangladesh is for protecting vulnerable women. One of the suggested currently implementing a wide range of actions against benefits of the female-controlled HIV/STI prevention HIV/AIDS. It is likely that the vaginal microbicides will options include the fact that being under the control of become one of the prevention options as soon as one women, these prevention options might be used discretely becomes available. In that circumstance, the professional without the partner's knowledge. For example, a study in might be expected to play key roles in the social marketing of Zimbabwe reported that about 13% of women surveyed these products. To the best of our knowledge, we are not used the female condoms without their partners' 10 aware of any reports on the attitudes of Bangladeshi knowledge. Similar experience has been suggested as 11 professionals to the vaginal microbicide. This study was being even more possible with the vaginal microbicide. A conducted to explore the attitudes towards the femalenumber of reports from both developing and developed controlled HIV/STI prevention options with particular countries have suggested that the vaginal microbicide will 3, [9] [10] [11] [12] [13] [14] [15] reference to the female condom and vaginal microbicide and be an acceptable HIV/STI prevention option.
their acceptability among Bangladeshi professionals. While the use of the female condom has not been 16, 17 encouraging, reports indicate that with appropriate motivation, female condom acceptability is likely to This was a cross-sectional descriptive study conducted 16, 17 increase. On the other hand, no vaginal microbicide has among professionals in Dhaka, the capital city of Bangladesh. yet been approved for use in HIV/AIDS prevention;
The participants included medical doctors, pharmacists, however, the results of the Caprisa 004 study in South Africa nurses and secondary school teachers. Each professional was has given hope that a microbicide may become available required to complete a self administered semi-structured soon. In addition, several reports have suggested that people questionnaire. In addition to their demographic details, from diverse socio-economic backgrounds would be questions were asked about their HIV risk perception, male 9, 10, 12, 13 willing to use the vaginal microbicide. It is likely that and female condom use experiences, and their attitudes the subordinate roles that women play in most societies towards female-controlled HIV/STI prevention options with could potentially be a barrier to their use of an effective particular reference to the vaginal microbicide. The data microbicide even if they desire to do so. And one issue that generated was analyzed using descriptive statistics. Various has been in the front burner since the early days of responses were first analyzed using proportions and microbicides advocacy is the feasibility of finding a large percentages. Associations between variables were assessed enough market for the product when one is eventually using student t-test for continuous variables, and chi-squared [18] [19] [20] developed. There have been suggestions that key opinion test for categorical variables. Multivariable logistic leaders such as health care professionals could significantly regression analysis was used to control for confounders and to influence the acceptability and actual use of the vaginal identify independent predictors of risk perception, 12, 21 microbicides. However, there is paucity of information willingness to use female condom and willingness to use on the attitudes of these professionals towards these vaginal microbicide. A p-value below 0.05 was considered as products. Although there have been studies relating to the statistically significant. STATA version 8 (Stata Corporation, influence of family planning providers on the use of female College Station, TX, USA) was used in the analysis. 16, 17 condoms in many developing countries, non-family planning providers are also involved in the management and care of patients with STIs and HIV. Therefore
Demographic characteristics understanding the attitudes of other health care
Three hundred and seventy five professionals participated professionals to the female-controlled HIV/STI prevention in the study comprising 184 males (49.1%) and 191 females options will inform the design of appropriate interventions (50.9%). The age range was 18-54 years (mean 35.4 years, to promote the use of these products. Furthermore, since the SD 6.9 years). The males were significantly younger than female condom is also a female-controlled HIV/STI the females (mean age 34.4 years vs. 36.4 years, p=0.005). prevention option, it is likely that factors which affect its use Eighty-eight (23.5%) of the respondents were single, 265 might also affect the use of the vaginal microbicide.
(70.7%) were married, while 22 (5.9%) were widowed, separated or divorced. Significantly more females than Bangladesh has a population of 150 million and covers an males were in a marriage relationship (P<0.001). area of about 147,570 square kilometers. Although the
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South East Asia Journal of Public Health 2012;2 (1) Table 1 : Association between profession, marital status and probably due to the small numbers of respondents. Of all the sexual partners in the last 12 months respondents, 122 (32.5%) were medical doctors, 114 (30.4%) were nurses, 70 (18.7%) were pharmacists while 69 (18.4%) were teachers. Approximately 70-90% of the doctors, nurses and teachers were married while only 40% of the pharmacists were married. The relationship between profession, marital status, number of years of professional practice and sexual partners are shown in Table 1 and Table  2 .
Acceptability of female-controlled HIV/STI prevention options
Three hundred and sixty-nine (98.4%) respondents agreed that women should be allowed to determine their HIV/STI prevention options. Of the six that felt that women should not be allowed to determine their HIV/STI prevention option, one person felt that this would cause women to begin to disrespect men and two respondents felt that the culture forbids a woman from taking such actions. The other three did not give any reason. When the respondents were asked if an HIV/STI prevention option which empowers the woman such as the female condoms and vaginal microbicides would be acceptable, 335 (89.3%) agreed, 9 (2.4%) profession in a multivariable logistic regression, both previous use of male condom and current use of the male Only 69 (18.4%) respondents showed their willingness to condom were strongly associated with willingness to use use the female condoms. About 41% of the pharmacists, the female condom. Respondents who have ever used the 23.8% of the doctors and 8.8% (10/114) of the nurses male condoms were 2.7 times more likely to be willing to expressed their willingness to use the female condoms use the female condoms than those who had never used the ( Figure 1 ). Among those who have heard of the female male condoms (95% CI: 1.16 to 6.29), while those who condom, only 38 (14.5%) will be willing to use it; 113 currently use the male condoms are about twice as likely to (43.1%) will not, while 111 (42.4) are undecided. About be willing to use the female condoms than those who do not 45.2% of those who have seen the female condom will not currently use the male condoms (95% CI: 1.16 to 3.13). be willing to use it. In a multivariable logistic regression However, after controlling for the above confounders, there analysis with willingness to use the female condom as the was no association between previous or present use of the dependent variable, the factors that were significantly male condom and willingness to use or support the use of the associated with willingness to use female condom were vaginal microbicide (Table 4) . Table 5 
Discussion
ultimately the decision to use any of these products might depend largely on the women. However this observation, This study suggests that professionals would support which challenges the widely acknowledged power female-controlled HIV/STI prevention options particularly imbalance with respect to sexual decisions in favor of the the vaginal microbicides, a finding which is similar to earlier 23 12,13, [22] [23] [24] men, should be interpreted with caution. It is likely that this reports from other parts of the world.
As in these observation might relate specifically to our study population earlier reports, we found a big support by these professionals who were a highly socio-economically empowered group. for a policy which allows women to determine their Similar assertiveness might not be found among the less HIV/STI prevention options. Taken together, these reports empowered lower socio-economic classes of women. suggest a growing global consensus on the need to empower women to protect themselves from HIV and other STIs.
We had proposed that since the female condom is also a female-controlled HIV/STI prevention option, factors The finding that significantly fewer women would be associated with its use might also affect the use of the willing to support their spouses' decisions to use either the vaginal microbicide. In this study however, we did not find any association strong association between sexual activity and perception of between willingness to use the female condom and personal risk of HIV infection on the one hand, and willingness to use the vaginal microbicide, although some willingness to use the vaginal microbicides on the other 25 of the independent predictors of willingness to use the hand is similar to the report by Bentley et al., suggesting female condom were also independent predictors of that HIV risk perception might play a crucial role in an willingness to use the vaginal microbicide. It is likely that individual's decision to use vaginal microbicides. these independent predictors which were common to both Furthermore, our data suggests that while these products operate at different levels. The possible professionals may not use the microbicides because of their implication of this finding is that the pattern of female low HIV risk, they would readily recommend it to those who condom utilization might not correctly predict the pattern of are at higher risk of HIV, a finding that is important for the vaginal microbicide utilization.
social marketing of the microbicide.
The finding that fewer number of respondents have seen the In this study, we found no association between previous and female condom compared to those who have heard of it current male condom use with willingness to use vaginal might reflect the fact that many of those who have not seen it microbicide, contrary to the fears expressed by some were either not sexually active or were in a monogamous workers that the microbicides when eventually approved relationship, and therefore did not need a female condom.
will replace the condom and if not efficacious might have a 26 Alternatively, this might reflect poor social marketing of the negative impact on HIV control. This finding is similar to 27 female condom. The third possible reason for fewer people the observation by Malow et al. that condom use rate did having seen the female condom could relate to the finding not decrease because of the presence of alternative HIV/STI that only few pharmacists, who should be marketing these prevention methods. In addition, our findings highlights the products, have heard of the female condom, more than a problems with extrapolating results of acceptability and decade after its introduction into the market.
other behavioral studies involving the male condom to vaginal microbicides. In contrast to the female condom, majority would be willing to support the use of the vaginal microbicides, even though
The issues identified in this study which might affect the fewer numbers will be willing to use it themselves even if acceptability of these products such as fear of possible side they knew that it was effective in preventing HIV/STI. The effects, potential effects on sexual enjoyment, and cultural,
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